Feed aggregator

How Companies Are Upping Diversity Among Clinical Trial Participants

Biospace news - Wed, 10/18/2023 - 02:00
How Companies Are Upping Diversity Among Clinical Trial Participants 10/18/2023

J&J’s Christopher Whelan on How—and Why—13 Companies Teamed up to Tackle Proteomics

Biospace news - Wed, 10/18/2023 - 02:00
J&J’s Christopher Whelan on How—and Why—13 Companies Teamed up to Tackle Proteomics 10/18/2023

Talent Acquisition Turns Introspective in a Cooler Market, and Other Things We Learned at LEAP TA...

Biospace news - Wed, 10/18/2023 - 02:00
Talent Acquisition Turns Introspective in a Cooler Market, and Other Things We Learned at LEAP TA... 10/18/2023

J&J Sees Nearly 7% Growth in Q3, Increases Full-Year Guidance

Biospace news - Tue, 10/17/2023 - 02:00
J&J Sees Nearly 7% Growth in Q3, Increases Full-Year Guidance 10/17/2023

Merck Pushes Keytruda into Perioperative NSCLC Setting with FDA Approval

Biospace news - Tue, 10/17/2023 - 02:00
Merck Pushes Keytruda into Perioperative NSCLC Setting with FDA Approval 10/17/2023

AbbVie’s Skyrizi Beats Remission Rates of J&J’s Stelara in Crohn’s Disease

Biospace news - Tue, 10/17/2023 - 02:00
AbbVie’s Skyrizi Beats Remission Rates of J&J’s Stelara in Crohn’s Disease 10/17/2023

Aldeyra Anticipates FDA Rejection of Dry Eye Drug Following Regulatory Meeting

Biospace news - Tue, 10/17/2023 - 02:00
Aldeyra Anticipates FDA Rejection of Dry Eye Drug Following Regulatory Meeting 10/17/2023

Omeros Shares Plummet on Phase III Kidney Disease Trial Failure

Biospace news - Mon, 10/16/2023 - 02:00
Omeros Shares Plummet on Phase III Kidney Disease Trial Failure 10/16/2023

Novo in $1.3B Deal Buys Late-Stage Hypertension Drug from Singapore Biotech

Biospace news - Mon, 10/16/2023 - 02:00
Novo in $1.3B Deal Buys Late-Stage Hypertension Drug from Singapore Biotech 10/16/2023

Pfizer Kicks Off $3.5B Cost-Cutting Program as COVID Revenues Decline

Biospace news - Mon, 10/16/2023 - 02:00
Pfizer Kicks Off $3.5B Cost-Cutting Program as COVID Revenues Decline 10/16/2023

Lilly’s Tirzepatide Shows Strong Weight Loss Efficacy in Phase III Study

Biospace news - Mon, 10/16/2023 - 02:00
Lilly’s Tirzepatide Shows Strong Weight Loss Efficacy in Phase III Study 10/16/2023

Experts Implore FDA to Accept Biomarker Evidence in Ultra-Rare Diseases

Biospace news - Mon, 10/16/2023 - 02:00
Experts Implore FDA to Accept Biomarker Evidence in Ultra-Rare Diseases 10/16/2023

FDA Action Alert: Merck, Ardelyx, BioMarin and More

Biospace news - Mon, 10/16/2023 - 02:00
FDA Action Alert: Merck, Ardelyx, BioMarin and More 10/16/2023

Opinion: Interest in RNA Editing Accelerates as Therapies Approach the Clinic

Biospace news - Mon, 10/16/2023 - 02:00
Opinion: Interest in RNA Editing Accelerates as Therapies Approach the Clinic 10/16/2023

FDA Approves Pfizer’s Ulcerative Colitis Drug, $6.7B Arena Buy Pays Off

Biospace news - Fri, 10/13/2023 - 02:00
FDA Approves Pfizer’s Ulcerative Colitis Drug, $6.7B Arena Buy Pays Off 10/13/2023

Early October Sees Torrid Pace of Biotech M&A—Will It Continue?

Biospace news - Fri, 10/13/2023 - 02:00
Early October Sees Torrid Pace of Biotech M&A—Will It Continue? 10/13/2023

Cassava Defends Alzheimer’s Asset in Response to Data Manipulation Allegations

Biospace news - Fri, 10/13/2023 - 02:00
Cassava Defends Alzheimer’s Asset in Response to Data Manipulation Allegations 10/13/2023

DaVita Casts Doubt on Novo’s Chronic Kidney Disease Results for Ozempic

Biospace news - Fri, 10/13/2023 - 02:00
DaVita Casts Doubt on Novo’s Chronic Kidney Disease Results for Ozempic 10/13/2023

BioNTech Inks Potential $1B Deal with MediLink for Cancer-Focused ADCs

Biospace news - Fri, 10/13/2023 - 02:00
BioNTech Inks Potential $1B Deal with MediLink for Cancer-Focused ADCs 10/13/2023

Relay Therapeutics Pauses Lirafugratinib Rare Cancer Plans Due to IRA

Biospace news - Fri, 10/13/2023 - 02:00
Relay Therapeutics Pauses Lirafugratinib Rare Cancer Plans Due to IRA 10/13/2023